Taxes (Tables)
|
12 Months Ended |
Jan. 01, 2022 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of significant components of the consolidated deferred tax assets and liabilities |
Significant components of the consolidated deferred tax assets and liabilities were (in thousands): | | | | | | | | | | | | | Fiscal Year | 2021 | | 2020 | | Deferred income tax assets: | | | | |
|
| Inventory | 3,348 | | | 4,095 | | |
|
| Compensation | 12,977 | | | 14,028 | | |
|
|
|
|
|
| Property, plant and equipment | 319 | | | — | | | Trade names and customer lists | 4,243 | | | 5,163 | | | Goodwill | 11,096 | | | 13,189 | | |
| Undistributed earnings of certain foreign subsidiaries | 57 | | | — | | | Foreign accruals | 11,446 | | | 12,582 | | | Loss carryforwards | 57,264 | | | 54,112 | | | Tax credit carryforwards | 5,715 | | | 2,771 | | |
|
| Interest disallowance | 8,977 | | | 9,604 | | |
|
| Lease liabilities | 32,830 | | | 54,857 | | | Other | 18,979 | | | 19,042 | | | Deferred income tax assets total | $ | 167,251 | | | $ | 189,443 | | |
| Deferred income tax liabilities: | | | | |
|
| Property, plant and equipment | — | | | (5,807) | | | Undistributed earnings of certain foreign subsidiaries | — | | | (3,076) | | | Right-of-use assets | (19,469) | | | (36,584) | | | Other | (780) | | | (1,327) | | | Deferred income tax liabilities total | $ | (20,249) | | | $ | (46,794) | | |
| Valuation allowance | (122,953) | | | (109,250) | | |
| Net deferred income tax assets | $ | 24,049 | | | $ | 33,399 | | | | | | | Net deferred income tax assets | $ | 24,553 | | | $ | 33,894 | | | Net deferred income tax liabilities | (504) | | | (495) | | | Net deferred income tax assets | $ | 24,049 | | | $ | 33,399 | |
|
| Schedule of the amounts and the fiscal year of expiration of loss carryforwards |
The amounts and the fiscal year of expiration of the loss carryforwards are (in thousands): | | | | | | | Expires 2022 through 2026 | $ | 22,053 | | | Expires 2027 through 2031 | 50,906 | | | Expires 2032 through 2036 | 15,770 | | | Expires 2037 through 2041 | 85,586 | | | Indefinite | 31,443 | | | Total loss carryforwards | $ | 205,758 | | The state apportioned amounts and the fiscal year of expiration of the loss carryforwards are (in thousands): | | | | | | | Expires 2022 through 2026 | $ | 5,817 | | | Expires 2027 through 2031 | 17,219 | | | Expires 2032 through 2036 | 22,358 | | | Expires 2037 through 2041 | 67,583 | | | Indefinite | 59,178 | | | Total loss carryforwards | $ | 172,155 | |
|
| Schedule of income before income taxes for the Company's U.S. and non-U.S. based operations |
The following table identifies income (loss) before income taxes for the Company's U.S. and non-U.S. based operations for the fiscal years indicated (in thousands): | | | | | | | | | | | | | | | | | | | Fiscal Year | 2021 | | 2020 | | 2019 | | U.S. | $ | (32,423) | | | $ | (163,331) | | | $ | (142,141) | | | Non-U.S. | 85,474 | | | (8,652) | | | 110,810 | | | Total | $ | 53,051 | | | $ | (171,983) | | | $ | (31,331) | |
|
| Components of provision for income taxes |
The Company's provision for income taxes consisted of the following for the fiscal years indicated (in thousands): | | | | | | | | | | | | | | | | | | | Fiscal Year | 2021 | | 2020 | | 2019 | | Current provision: | | | | | | | U.S. federal | $ | 1,714 | | | $ | (96,224) | | | $ | 2,338 | | | Non-U.S | 17,027 | | | 16,522 | | | 28,109 | | | State and local | (274) | | | (681) | | | (2,330) | | | Total current | 18,467 | | | (80,383) | | | 28,117 | | | Deferred provision (benefit): | | | | | | | U.S. federal | — | | | — | | | — | | | Non-U.S | 7,960 | | | 4,340 | | | (9,436) | | | State and local | — | | | — | | | — | | | Total deferred | 7,960 | | | 4,340 | | | (9,436) | | | Provision for income taxes | $ | 26,427 | | | $ | (76,043) | | | $ | 18,681 | |
|
| Reconciliation of the U.S. federal statutory income tax rate to the effective tax rate |
A reconciliation of the U.S. federal statutory income tax rates to the Company's effective tax rate is as follows: | | | | | | | | | | | | | | | | | | | Fiscal Year | 2021 | | 2020 | | 2019 | | Tax at statutory rate | 21.0 | % | | 21.0 | % | | 21.0 | % | |
| Permanent differences | (2.5) | | | (4.5) | | | (2.0) | | | State, net of federal tax benefit | (2.0) | | | (0.1) | | | 17.6 | | | Foreign rate differential | (3.8) | | | 1.2 | | | 12.8 | | | Withholding taxes | 7.5 | | | (1.2) | | | (11.1) | | | GILTI tax-net of foreign tax credits | 5.7 | | | 2.1 | | | (24.2) | | | U.S. tax on foreign income-net of foreign tax credits | — | | | 3.9 | | | 0.3 | | | Income tax contingencies | 3.9 | | | 1.6 | | | 3.2 | | | Valuation allowances | 31.9 | | | (0.4) | | | (53.2) | | | R&D/Foreign Tax Credits | (5.6) | | | — | | | — | | | Deficiencies (Benefits) on employee stock awards | (0.3) | | | (1.4) | | | (10.9) | | |
| APB23 Assertion | (6.9) | | | — | | | — | | |
| Foreign deferred tax rate change | (1.1) | | | — | | | (4.5) | | | Non deductible foreign equity awards | 0.8 | | | (0.4) | | | (3.2) | | | Non deductible officer compensation | 1.0 | | | 0.7 | | | (3.7) | | | Tax exempt foreign capital gain income | — | | | — | | | 6.3 | | | Deferred adjustment | — | | | — | | | (8.0) | | | CARES Act Rate Benefit | — | | | 21.7 | | | — | | | Other | 0.2 | | | — | | | — | | | Provision for income taxes | 49.8 | % | | 44.2 | % | | (59.6) | % |
|
| Reconciliation of the total amounts of unrecognized tax benefits |
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits for the fiscal years indicated (in thousands): | | | | | | | | | | | | | | | | | | | Fiscal Year | 2021 | | 2020 | | 2019 | | Balance at beginning of year | $ | 31,540 | | | $ | 35,676 | | | $ | 39,909 | | | Gross increases—tax positions in prior years | 2,266 | | | 1,241 | | | 6,639 | | | Gross decreases—tax positions in prior years | (3,016) | | | (4,281) | | | (4) | | | Gross increases—tax positions in current year | 1,120 | | | 857 | | | 184 | | | Settlements | (630) | | | — | | | (1,901) | | | Lapse in statute of limitations | (1,188) | | | (2,255) | | | (8,912) | | | Change due to currency revaluation | (259) | | | 302 | | | (239) | | | Balance at end of year | $ | 29,833 | | | $ | 31,540 | | | $ | 35,676 | |
|